A cross-national study of depression in preclinical dementia: A COSMIC collaboration study.


Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
11 2020
Historique:
received: 17 02 2020
revised: 15 05 2020
accepted: 23 07 2020
pubmed: 4 9 2020
medline: 28 9 2021
entrez: 4 9 2020
Statut: ppublish

Résumé

Depression commonly accompanies Alzheimer's disease, but the nature of this association remains uncertain. Longitudinal data from the COSMIC consortium were harmonized for eight population-based cohorts from four continents. Incident dementia was diagnosed in 646 participants, with a median follow-up time of 5.6 years to diagnosis. The association between years to dementia diagnosis and successive depressive states was assessed using a mixed effect logistic regression model. A generic inverse variance method was used to group study results, construct forest plots, and generate heterogeneity statistics. A common trajectory was observed showing an increase in the incidence of depression as the time to dementia diagnosis decreased despite cross-national variability in depression rates. The results support the hypothesis that depression occurring in the preclinical phases of dementia is more likely to be attributable to dementia-related brain changes than environment or reverse causality.

Identifiants

pubmed: 32881298
doi: 10.1002/alz.12149
pmc: PMC7666102
mid: NIHMS1621194
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1544-1552

Subventions

Organisme : NIA NIH HHS
ID : R01 AG012975
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG023651
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG057531
Pays : United States

Informations de copyright

© 2020 the Alzheimer's Association.

Références

J Glob Health. 2019 Jun;9(1):011001
pubmed: 30997043
Neurology. 2010 Jul 6;75(1):21-6
pubmed: 20603481
Am J Geriatr Psychiatry. 2018 Aug;26(8):819-827
pubmed: 29960668
J Psychiatry Neurosci. 2004 Nov;29(6):417-26
pubmed: 15644983
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:203-8
pubmed: 23276885
Neuroepidemiology. 1992;11 Suppl 1:84-7
pubmed: 1603256
Arch Gen Psychiatry. 2008 May;65(5):542-50
pubmed: 18458206
Psychol Med. 1991 Feb;21(1):225-36
pubmed: 2047500
Biol Psychiatry. 2002 Aug 1;52(3):243-52
pubmed: 12182930
Alzheimers Dement. 2018 Jun;14(6):703-706
pubmed: 29842864
Int J Geriatr Psychiatry. 2011 Sep;26(9):944-51
pubmed: 21845597
Int J Geriatr Psychiatry. 2009 Nov;24(11):1277-84
pubmed: 19340894
Biol Psychiatry. 2003 Aug 1;54(3):353-62
pubmed: 12893110
Int Psychogeriatr. 2010 Dec;22(8):1248-64
pubmed: 20637138
J Alzheimers Dis. 2014;42(3):739-55
pubmed: 24946876
Br J Psychiatry. 2013 May;202(5):329-35
pubmed: 23637108
Br J Psychiatry. 1996 Mar;168(3):287-91
pubmed: 8833681
Br J Psychiatry. 2001 Sep;179:250-4
pubmed: 11532803
Am J Psychiatry. 1994 Jul;151(7):1006-9
pubmed: 8010355
J Am Geriatr Soc. 2003 Feb;51(2):169-77
pubmed: 12558712
Neurology. 2010 Jul 6;75(1):35-41
pubmed: 20603483
Dement Geriatr Cogn Disord. 2002;13(1):8-12
pubmed: 11731709
J Nutr Health Aging. 2011 Aug;15(8):609-17
pubmed: 21968854
Arch Gen Psychiatry. 2008 Apr;65(4):439-45
pubmed: 18391132
Acta Psychiatr Scand. 2006 Dec;114(6):398-410
pubmed: 17087788
J Clin Psychiatry. 2016 Mar;77(3):e305-11
pubmed: 26891108
BMJ. 2010 Aug 05;341:c3885
pubmed: 20688841
Psychiatry Investig. 2018 Aug;15(8):767-774
pubmed: 30086611
BMC Neurol. 2013 Nov 06;13:165
pubmed: 24195705
Lancet Psychiatry. 2016 Jul;3(7):628-35
pubmed: 27138970
BMC Geriatr. 2013 Sep 24;13:98
pubmed: 24063518
Int J Epidemiol. 2014 Apr;43(2):365-406
pubmed: 24366490

Auteurs

Sophie Carles (S)

Neuropsychiatry: Epidemiological and Clinical Research, INSERM, Montpellier University, Montpellier, France.

Isabelle Carrière (I)

Neuropsychiatry: Epidemiological and Clinical Research, INSERM, Montpellier University, Montpellier, France.

Simone Reppermund (S)

Centre for Healthy Brain Ageing, University of New South Wales, Sydney, New South Wales, Australia.

Annalisa Davin (A)

Golgi Cenci Foundation, Milan, Italy.

Antonio Guaita (A)

Golgi Cenci Foundation, Milan, Italy.

Roberta Vaccaro (R)

Golgi Cenci Foundation, Milan, Italy.

Mary Ganguli (M)

Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Erin P Jacobsen (EP)

Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Joanne C Beer (JC)

Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Steffi G Riedel-Heller (SG)

Institute of Social Medicine, Occupational Health and Public Health, Medical Faculty, University of Leipzig, Leipzig, Germany.

Susanne Roehr (S)

Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco, California, USA.

Alexander Pabst (A)

Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco, California, USA.

Mary N Haan (MN)

Dementia Collaborative Research Centre, University of New South Wales, Sydney, New South Wales, Australia.

Henry Brodaty (H)

Department of Developmental Disability Neuropsychiatry, School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia.

Nicole A Kochan (NA)

Centre for Healthy Brain Ageing, University of New South Wales, Sydney, New South Wales, Australia.

Julian N Trollor (JN)

Centre for Healthy Brain Ageing, University of New South Wales, Sydney, New South Wales, Australia.
Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, South Korea.

Ki Woong Kim (KW)

Department of Psychiatry, College of Medicine, Seoul National University, Seoul, South Korea.
Department of Brain and Cognitive Sciences, College of Natural Sciences, Seoul National University, Seoul, South Korea.

Ji Won Han (JW)

Department of Psychiatry, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea.

Seung Wan Suh (SW)

Department of Medicine and Psychiatry, Universidad de Zaragoza, Zaragoza, Spain.

Antonio Lobo (A)

Centro de Investigación Biomédica en Red de Salud Mental, Ministry of Science and Innovation, Madrid, Spain.
Hospital Clínico Universitario, Zaragoza, Spain.

Concepción De la Camara (C)

Centro de Investigación Biomédica en Red de Salud Mental, Ministry of Science and Innovation, Madrid, Spain.
Hospital Clínico Universitario, Zaragoza, Spain.
Instituto de Investigación Sanitaria Aragón, Zaragoza, Spain.
Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, Scotland, UK.

Elena Lobo (E)

Institute of Social Medicine, Occupational Health and Public Health, Medical Faculty, University of Leipzig, Leipzig, Germany.
Department of Developmental Disability Neuropsychiatry, School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia.
Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, Scotland, UK.

Darren M Lipnicki (DM)

Centre for Healthy Brain Ageing, University of New South Wales, Sydney, New South Wales, Australia.

Perminder S Sachdev (PS)

Centre for Healthy Brain Ageing, University of New South Wales, Sydney, New South Wales, Australia.
Department of Microbiology, Preventive Medicine and Public Health, Universidad de Zaragoza, Zaragoza, Spain.

Marie-Laure Ancelin (ML)

Neuropsychiatry: Epidemiological and Clinical Research, INSERM, Montpellier University, Montpellier, France.

Karen Ritchie (K)

Neuropsychiatry: Epidemiological and Clinical Research, INSERM, Montpellier University, Montpellier, France.
Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, Scotland, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH